Iaso Ventures
Venture capitalCambridge · Seed–Series A · 14 people tracked
Also known as IASO VENTURES MANAGEMENT FIRM LLC
Find your way into Iaso Ventures
4,576 people in our graph share verified history with the Iaso Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Iaso Ventures invests in game-changing life sciences and healthcare startups working to cure disease and improve patient outcomes. The firm backs data-driven enabling technologies and platforms that support next-generation therapeutic development. Drawing on an investor-operator background and a collaborative, industry-wide approach, Iaso leverages deep sector expertise to accelerate growth and create value. Its mission centers on pursuing the bleeding edge of healthcare innovation while staying grounded in serving patients and maximizing well-being.
Source: firm website, verified Sep 15, 2026.
Team · 14 people
from the firm's website & public directories
What they invest in
from 22 of 28 portfolio companiesHealthtech ×16Biotech ×15Medical Devices ×9Digital Health ×8Deep Tech ×7AI & Machine Learning ×5Data & Infrastructure ×3SaaS ×3
HQs:United States×13Canada×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×62 founders×63 founders×2
Where their founders studiedfrom 14 founders with education data
University of California, Berkeley ×2
What their founders studiedfrom 15 founders with field-of-study data
Engineering ×6Life Sciences ×4Business & Management ×3Chemistry ×3Economics ×2Medicine ×2
Where their founders worked beforefrom 16 founders with career history
Health Catalyst ×2
Accelerator rootsportfolio companies that came through a program
Investments · 28 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 32023 · 22022 · 42021 · 113 dated
Certara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases.
AI & Machine LearningBiotechHealthtechSaaSRadnor, US
Adrian McKemey(President, Certara Drug Development Solutions)inRona Anhalt(Chief Human Resources Officer)inDaniel Corcoran(SVP and General Counsel)inLeif Pedersen(President, Chief Commercial Officer)inWilliam Feehery(CEO and Director)inJieun W. Choe(Chief Strategy & Marketing Officer)in
Board seatJohn Reynders· per SEC Form D · filed Apr 2026
Co-investorsArsenal
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Co-Founder)inJack O’Meara(Cofounder)in
Co-investorsage1BackedBlueYard CapitalEntrepreneur FirstPsyMed VenturesSpeedinvest+4 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.
BiotechDigital HealthHealthtechMedical DevicesSammamish, US
Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)
Co-investorsJAZZ Venture PartnersLumira VenturesAngelini VenturesF-Prime Capital
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Marco Lobba(Founder)inMatthew Francis(Founder)in
Co-investorsCALIFORNIA INNOVATIONCivilization Ventures Management, LlcCreative Destruction Lab (CDL)MBX CapitalY CombinatorAxial VC+2 more
Celéri builds real-world evidence infrastructure that connects point-of-care outcomes, commercial registries, and regulatory-grade data for medtech and pharma sponsors, interventional pain physicians, and payers.
Digital HealthHealthtechMedical Devices
Co-investorsTwelve Below
Data & InfrastructureHealthtechPasadena, US
Wout Brusselaers(Executive Officer, Director)inSondra Pepe(Executive Officer)inChristian Duvall(Executive Officer)inAntonia Holway(Executive Officer)inDoug Cassidy(Executive Officer)inPeter Casasanto(Executive Officer)in
Co-investorsInformed Ventures Advisors, LlcPoint72 VenturesTechstarsTMC Venture FundGSR Ventures
EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers.
Digital HealthHealthtechMedical DevicesBaltimore, US
Nathan Crone(Executive Officer, Director, Promoter)Gregory Krauss(Executive Officer, Director, Promoter)Teresa Prego(Executive Officer, Director)inDean Papadopoulos(Executive Officer, Director, Promoter)
BoardDaniel Hanley(Director)Richard Schmitt(Director)
Co-investorsMaryland TEDCOTEDCO
Mensura Health is developing an electrochemical point-of-care diagnostic system that uses DNA aptamer-based sensors and disposable microfluidic cartridges to rapidly measure blood levels of anti-seizure medications in epilepsy patients.
BiotechDigital HealthMedical DevicesWeston, US
Steven Schachter(Founder & Head Scientific Advisor)inNancy Hsiung(Founder & Chief Operating Officer)Charles Keough(Founder & Chief Executive Officer)Valentin Gribkoff(Executive Officer, Director)
BoardRobert Smith(Independent Director, Chairman of the Board)
Neumirna develops miRNA-based therapies for neurological diseases such as epilepsy and Parkinson's.
BiotechLongevity
Co-investorsInvivo Capital PartnersSunstone Capital
Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions.
BiotechFemTechHealthtechMedical DevicesCalgary, CA
Claire Dixon(CEO & Co-Founder)inPierre Wijdenes(CPO & Co-Founder)in
Co-investorsStartup TNTBoxOne Ventures
Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.
BiotechDeep TechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)
Co-investorsBerkeley FrontierThe Column GroupYsios CapitalAlexandriaFidelity InvestmentsLYFE Capital+7 more
Prudentia Sciences provides information and evaluation services for biotech and pharmaceutical companies to help investors and acquirers assess breakthrough therapies before due diligence begins.
AI & Machine LearningBiotechEnterprise SoftwareHealthtech
Sadiqa Mahmood(CEO & Founder)in
Co-investorsGeneral AtlanticMcKesson VenturesVirtue Ventures
Ryght AI provides an artificial intelligence-powered platform that uses digital twin technology to help clinical research organizations and sponsors identify and select optimal sites for clinical trials.
AI & Machine LearningBiotechHealthtechMedical Devices
Dr. Chadi Nabhan(Chief Medical Officer)Tom Pike(President and Chief Executive Officer)
Co-investorsAIX VenturesFoothill VenturesPage One VenturesVirtue VenturesLDV PartnersTop Harvest Capital
Statcounter provides website analytics and visitor tracking software that displays traffic data, user behavior, and engagement metrics in a simple interface.
AdTechData & InfrastructureMarketing TechSaaS
Aodhán Cullen(Founder and CEO)
Co-investorsGabriel Venture PartnersHomegrown CapitalHuangpu River CapitalKumpulan Modal PerdanaNucleation CapitalNventure+2 more
Tuva provides infrastructure and data standardization solutions for healthcare analytics teams, enabling them to transform raw healthcare data into analysis-ready datasets.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSSalt Lake City, US
Aaron Neiderhiser(Founder)inCoco Zuloaga(Founder)in
Co-investorsVirtue VenturesY Combinator
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Co-investorsAcequia Capital (AceCap)BlueYard CapitalGlobal BrainHAWKTAILimec.xpandRaptor Group+2 more
Zeto develops improved electroencephalography technology for diagnosing epilepsy and other neurological conditions.
Cloud ComputingDeep TechDigital HealthHealthtechMedical DevicesSan Francisco, US
Aswin Gunasekar(Founder and CEO)in
Co-investorsAphelion Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sea PharmaceuticalsBeacon BiosignalsHexokine TherapeuticsPragma BioScaffold TherapeuticsSoovu
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsCertaraNASDAQ: CERT
Portfolio news
latest coverage across their companies
Beacon Biosignals · finance.yahoo.com · Apr 7, 2026
Tuva Health · outofpocket.health · Mar 23, 2026
Ryght · indianweb2.com · Dec 13, 2025
Frequently asked questions
- How many investments has Iaso Ventures made?
- Iaso Ventures has 28 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
- What stage does Iaso Ventures invest at?
- Iaso Ventures invests at the Seed, Series A stages.
- What sectors does Iaso Ventures focus on?
- Iaso Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Iaso Ventures located?
- Iaso Ventures is headquartered in Cambridge, US.
- Who does Iaso Ventures co-invest with?
- Iaso Ventures most often shares deals with Virtue Ventures, BlueYard Capital, Civilization Ventures Management, Llc, among 53 tracked co-investors.
Co-investors · 1
Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.
Firms observed investing alongside Iaso Ventures, from public investor directories. Shared companies are the overlap with Iaso Ventures's recorded portfolio.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.